Davis Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Davis Capital Management’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$4.62K	Buy	74 +15	+25%	+$948	﹤0.01%	317
2026 Q2	$3.4K	Buy	59 +40	+211%	+$2.3K	﹤0.01%	345
2026 Q1	$1.15K	Buy	19 +6	+46%	+$350	﹤0.01%	322
2025 Q4	$701	Sell	13 -3	-19%	-$144	﹤0.01%	364
2025 Q3	$722	Buy	+16	New	+$747	﹤0.01%	364
2024 Q2	–	Sell	-582	Closed	-$30.8K	–	319
2024 Q1	$30.8K	Sell	582 -552	-49%	-$28.1K	0.03%	164
2023 Q4	$58.2K	Buy	+1,134	New	+$59.5K	0.06%	115
2020 Q2	$355K	Hold	6,038	–	–	0.66%	52
2020 Q1	$337K	Buy	+6,038	New	+$369K	0.72%	51

Other funds holding BMY

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $174B AUM 33.96% 1-Year Est. Return

KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return

Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $57B AUM 43.56% 1-Year Est. Return

Swedbank Stockholm, Sweden $118B AUM 40.52% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $91.6B AUM 30% 1-Year Est. Return

Davis Capital Management's BMY Position: Q3 2026 in Review

Davis Capital Management increased its Bristol-Myers Squibb (BMY) stake by 25% in Q3 2026, buying an estimated $948 and bringing the position to 74 shares worth $4.62K. The position accounts for ﹤0.01% of the portfolio, ranked #317.

Davis Capital Management first reported a position in BMY in Q1 2020 and has held it in 9 quarters since. The position peaked at $355K in Q2 2020. 1,223 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Davis Capital Management held 74 shares of Bristol-Myers Squibb worth $4.62K as of Q3 2026.
Davis Capital Management bought 15 Bristol-Myers Squibb shares in Q3 2026, an estimated $948.
Bristol-Myers Squibb made up ﹤0.01% of Davis Capital Management's portfolio in Q3 2026, its #317 holding.
Davis Capital Management first reported a position in Bristol-Myers Squibb in Q1 2020 and has held it in 9 quarters since.
Davis Capital Management's Bristol-Myers Squibb position peaked at $355K in Q2 2020.
1,223 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Davis Capital Management's 13F filing for Q3 2026, filed 8 Oct 2026.